Navigation Links
PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
Date:10/27/2009

ments had a favorable impact on earnings per share of approximately two cents in the current quarter.

On a segment basis, consolidated service revenue for the first quarter of Fiscal Year 2010 was $202.3 million in Clinical Research Services (CRS), $28.8 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $28.7 million in Perceptive Informatics, Inc.

Backlog at the end of September was approximately $2.157 billion. The reported backlog included gross new business wins of $322.1 million, cancellations of $100.7 million, a positive impact from foreign exchange rates of $21.7 million, and a negative impact from other adjustments of $2.4 million. The net book-to-bill ratio (defined as gross new business less cancellations divided by service revenue) was approximately 0.85 in the quarter. On a year-over-year basis, backlog at September 30, 2009 was up 4.7%.

Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "Despite a difficult market environment for both our industry and our Company, we were able to exceed our EPS expectations. Client mergers and portfolio reprioritizations have created some unevenness in the demand for our services as reflected in project proposal flow and time to award. At the same time, there appear to be promising signs of stabilization, and we continue to believe that we are a key solution to many of the challenges that our client industries face."

Mr. von Rickenbach continued, "Most importantly, we are focused on the future and are optimistic about what it holds for PAREXEL. After many years, we have achieved our goal of establishing a comprehensive global presence to better serve our clients. As part of our ongoing efforts to leverage these resources more strategically, we will be realigning our global cost structure to further capitalize upon the value that is inherent in our worldwide infrastructure. We believe that these steps will str
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
2. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
3. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
4. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
5. PAREXEL Expands Global Clinical Pharmacology Capabilities
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
8. NxStage(R) Reports Significant Interim FREEDOM Study Results
9. Hospira Reports Third-Quarter 2009 Results
10. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
11. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons ... the key link between the medical device industry and ... more in the coming years as the device industry ... According to research by benchmarking firm, Best Practices, ... gain an important edge is by harnessing new technology ...
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... no-touch UV disinfection robot, announced today that the General ... contract through November 2019.   This newly ... engage all levels of government purchasers, including Department of ... well as Homeland Security contacts purchasing solutions for the ...
(Date:12/22/2014)... MARLBOROUGH, Mass , Dec. 22, 2014 /PRNewswire/ -- ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today issued the following open ... Geert Cauwenbergh , Dr. Med. Sc. ... few days a number of inaccurate statements posted ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Inc.(Nasdaq: MSHL ), an oncology company focused on ... today that it will host its Annual Meeting of Stockholders ... offices of Morgan, Lewis & Bockius LLP, located at 101 ... vote on certain matters, including the approval of the transactions ...
... 10, 2011 Eli Lilly and Company (NYSE: ... Ph.D., will lead Lilly,s oncology research efforts as the vice ... research. In this innovative new role created by ... of both Lilly and its subsidiary, ImClone. Plowman will be ...
Cached Medicine Technology:Marshall Edwards to Host Annual Meeting of Stockholders 2Marshall Edwards to Host Annual Meeting of Stockholders 3Lilly Announces New Vice President of Oncology Research 2Lilly Announces New Vice President of Oncology Research 3
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... Analysis to 2023” focuses on the current treatment ... in the colorectal cancer market. Stivarga is a ... colon or rectal cancer. Boehringer Ingelheim is developing ... the treatment of refractory CRC in the US, ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
(Date:12/25/2014)... December 25, 2014 Plugin creators from ... 5k. A fully customizable business presentation tool made specifically ... the ProFire 5k business tool, users can now display ... CEO of Pixel Film Studios. “ProFire 5k gives users ... to add professionalism to a presentation” , Pixel Film ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... . , Montreal, January 14, 2009 Canadian researchers ... cancer. According to a recent study from the Universit de ... Journal of Biological Chemistry , the protein ARF1 plays a ... tumours. Targeting this protein with drug therapy may provide hope ...
... Only Non-Drowsy Allergy Medicine in a Liquid-Filled Capsule ... 14 Schering-Plough Corporation (NYSE: SGP ... Liqui-Gels(R), the first and only non-drowsy allergy medicine ... CLARITIN(R) Liqui-Gels(R) provide powerful liquid relief for the ...
... affected by chronic inflammation without knowing much about it. FlameEz.com is ... inflammation, the root cause of many of the most feared illnesses ... ... PA (PRWEB) January 14, 2009 -- Millions of Americans are affected ...
... N.C., Jan. 14 Germs are everywhere,and especially dangerous ... can age hands, ignite near flame and make kids ... www.remi-d.com ) dispenses with these maladies with subtle,scents, convenience ... sanitizers have been sick with laziness. Remi-D is ...
... Va., Jan. 14 ... solutions for healthcare, announced that the Unbound(TM) Platform ... iPod(R) touch devices. Adding delivery of iPhone applications ... Palm OS devices strengthens Unbound Medicine,s position as ...
... Specialty Line for Tweens and TeensCARLSBAD, Calif., Jan. 14 ... ages clarifying products that are 100% natural and ultra-effective ... The products include the Everyday Clarifying Lotion, Everyday Clarifying ... be debuting at the New York International Gift Fair, ...
Cached Medicine News:Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 3Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 3Health News:No Germs, No Fires, No Mess: New Product Makes Good Health Easy and Natural 2Health News:Unbound Medicine Announces Download Support for iPhone(TM) and iPod(R) Touch Devices 2Health News:Glory for Girls Announces All-Natural Clarifying Products for Clear and Radiant Skin 2
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
Medicine Products: